Screener
Avalo Therapeutics AVTX Business Segments — License and milestone expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept avtx:LicenseAndMilestoneExpenses.
The source filing: Avalo Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001534120-26-000049
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Nonclinical expenses | $249 | $179 | $640 | $262 |
| Clinical expenses | 3,712 | 7,215 | 9,344 | 11,065 |
| CMC expenses | 5,068 | 3,266 | 9,194 | 5,245 |
| License and milestone expenses | 10,000 | — | 10,000 | — |
| Internal expenses: | ||||
| Salaries, benefits and related costs | 2,630 | 2,181 | 5,216 | 4,030 |
| Stock-based compensation expense | 1,680 | 1,116 | 2,923 | 2,418 |
| Other | 79 | 117 | 149 | 175 |
Item 1. Financial Statements.
FAQ
- What is Avalo Therapeutics's business segments — license and milestone expenses?
- Avalo Therapeutics (AVTX) reported business segments — license and milestone expenses of $10M in Q2 2026.
- What does business segments — license and milestone expenses mean?
- This metric represents the costs incurred by a specific business segment related to the acquisition of intellectual property rights, including upfront license fees and payments triggered by the achievement of clinical or regulatory milestones. It reflects the capital-intensive nature of drug development and the strategic investment required to advance a proprietary pipeline of therapeutic assets. Monitoring these expenses provides insight into the company's commitment to external innovation and the financial obligations associated with its clinical-stage research programs.
Ask your AI about Avalo Therapeutics's business segments — license and milestone expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude